Navigation Links
MGT Capital Investments, Inc. Provides Update on Recent Developments
Date:8/22/2011

in London.  We anticipate that trading in MDST shares will resume as of the date of this press release and that shares of MGT will resume trading thereafter. There can be no guarantee that MDST stock will resume trading in London or that the NYSE Amex LLC will resume trading of MGT common stock upon the resumption of trading of MDST shares.

Summary Financial Results for the period ended June 30, 2011

For the six months ended June 30, 2011 revenues from licensing and other sales were $264,000, compared to $326,000 for the corresponding period in 2010. Total operating expenses for the six months ended June 30, 2011 were $5.2 million, compared to total operating expenses of $6.1 million in the comparable period for 2010.

For the quarter ended June 30, 2011, the Company reported a net loss of $2.9 million, or $0.07 per share, compared to a net loss of $4.0 million, or $0.12 per share, for the same period in 2010. Net loss per share for the quarter ended June 30, 2011 was based on weighted average of 39.5 million shares outstanding, compared to a weighted average of 32.5 million shares outstanding for the comparable period in 2010.

As noted above, based upon the preliminary results of the Special Committee investigations, the Company has concluded that no adjustments or restatement of our prior issued financial statements was required.  However, based upon the preliminary results of the investigation, an additional weakness in internal controls over financial reporting was identified surrounding the identification and disclosure for related party relationships and related party transactions.  We will assess the effectiveness of our remediation efforts in connection with our management's tests of internal control over financial reporting in conjunction with our December 31, 2011 financial statements.

At June 30, 2011 the Company reported cash and cash equivalents of $5.7 million compared to $8.4 milli
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
2. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
3. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
4. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
5. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
6. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
7. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
8. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
9. Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R)
10. New Fall Allergy Capitals(TM) Reveal the Most Challenging Cities for Allergy Sufferers
11. Accumetrics Announces $16.5M in New Capital Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
(Date:3/5/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... of chronic pain, today announced the appointment of ... The panel of experts will provide support for ... advance the company pipeline of novel investigational therapies ... a range of areas including opioid receptors, addiction, ...
(Date:3/5/2015)... 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss year-end 2014 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... , WASHINGTON, Dec. 3 ... that the " Help is Here Express " bus tour was in ... programs that provide prescription medicines for free or nearly free. , ... Partnership for Prescription Assistance ( PPA ) and sponsored by ...
... , ... arGEN-X BV, a,biopharmaceutical company focused on the discovery and development ... successful second closing of its Series A equity financing,round. The ... two leading life science investors, Credit Agricole Private Equity and,VIB ...
Cached Medicine Technology:'Help is Here Express' in Orlando to Help Floridians Afford Medicine 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected ... 2014 to 2019. , The global digital PCR (dPCR) and qPCR ... 2014 to 2019. Although the mature markets such as the U.S., ... (dPCR) and qPCR market the Asia-Pacific region is expected to grow ... growth of the digital PCR (dPCR) and qPCR market is driven ...
(Date:3/5/2015)... Bakersfield, CA (PRWEB) March 05, 2015 A ... following a seven-week trial awarding the plaintiff Coleen ... claimed as a result of a TVT-Abbrevo pelvic mesh sling ... Johnson. , Tom Cartmell , a partner at ... the trial team for the plaintiff, along with Rich Freese ...
(Date:3/5/2015)... March 05, 2015 Testosterone lawsuits ( ... suffered heart attacks, strokes and other serious cardiovascular events ... continue to move forward in the federal multidistrict litigation ... Illinois. According to a Case Management Order issued on ... the use of master pleadings in the proceeding. Among ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... March 05, 2015 SuperCloset has released a ... The series aims to teach viewers everything they need to ... Grow Like a SuperPro takes you from seed all the ... to clone, to how to prune Grow Like a SuperPro ... offering the whole series for download for a special introductory ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2
... HealthDay Reporter , THURSDAY, Oct. 13 (HealthDay News) -- ... tend to come on weekdays, specifically when your child should ... school avoidance, and it can take different forms in many ... by, but school avoidance "remains a serious problem," said Alan ...
... Washington, DC -- When transplant clinics must publicly report their ... for patients. But a recent study appearing in an upcoming ... Nephrology ( CJASN ) found that such public reporting ... patients receive. Public reports of the successes and ...
... By studying mice exposed to tobacco smoke for a period ... chronic obstructive pulmonary disease (COPD) develops. In the October ... they also report a promising new way to reverse the ... not been very clear what causes the disease and there ...
... could cause men to seek more sexual partners, giving them ... a social psychology professor at the University of Kansas. ... faced with a threatening environment, according to sexual selection theory ... about their own death, which mimics conditions of "low survivability," ...
... , THURSDAY, Oct. 13 (HealthDay News) --,Smoking ... are genetically susceptible to the mental health disorder, according ... population have the variant of the serotonin gene (5-HTT) ... Radboud University Nijmegen in the Netherlands. They analyzed ...
... Europe will have new avenues for scientific interaction, following ... EMBC, and the government of Singapore. The agreement will ... and activities. It also means that EMBO workshops and ... first cooperation agreement of its kind between EMBO, EMBC ...
Cached Medicine News:Health News:Why Johnny Won't Go to School 2Health News:Why Johnny Won't Go to School 3Health News:Reversing smoke-induced damage and disease in the lung 2Health News:Permanently dismal economy could prompt men to seek more sex partners 2Health News:Scientists in Singapore and Europe to collaborate 2
... The Alaris System integrates drug ... practice guidelines,into a single, modular platform. ... or remove modules as you,need them, ... the bedside,to a minimum while managing ...
... Eraser instruments have been designed to ... right tool for situations requiring precise ... of 25 gauge intraocular, bipolar, diathermy ... of target tissues for fine-tip hemostasis ...
... first steps any hospital or health system ... powerful, most effective tools available for physicians ... clinician documentation and electronic medical record (EMR) ... this goal. In fact, its the most ...
... Eraser instruments have been designed to ... right tool for situations requiring precise ... of 25 gauge intraocular, bipolar, diathermy ... of target tissues for fine-tip hemostasis ...
Medicine Products: